WanaB, It would be interesting to find out the answer to your question: " What, if any, action will be taken by the SEC with regard to that filing? Is that action on public record?" Unfortunately, I don't know the answer. Hopefully someone with more knowledge in this area can provide us with more information.
From filling:
On January 25, 2007, the CytoGenix, Inc. (the “Company”) received from the U.S. Department of Labor a complaint filed on behalf of Lawrence Wunderlich, the Company’s former chief financial officer and a former director, claiming whistleblower status under the Sarbanes-Oxley Act of 2002. The complaint alleges (i) violations of securities laws and Nevada corporate law by officers, directors, consultants, contractors and shareholders of the Company and (ii) violations by the Company of Securities & Exchange Commission disclosure requirements.
News 
Market Data 
Discover 
